Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement.

Ansell1

  • 1Department of Medicine, Boston University Medical Center, Boston, Massachusetts.

Journal of Thrombosis and Thrombolysis
|April 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure of liquid Y3Al5O12 (YAG)

Physical review letters·2000
Same author

Burrowing in the Antarctic anemone, Halcampoides sp., from Signy Island, Antarctica.

Journal of experimental marine biology and ecology·2000
Same author

Preface.

Journal of thrombosis and thrombolysis·2000
Same author

Introduction

Journal of thrombosis and thrombolysis·1999
Same author

Escape trajectories of the brown shrimp crangon crangon, and a theoretical consideration of initial escape angles from predators

The Journal of experimental biology·1998
Same author

Tail-flip mechanism and size-dependent kinematics of escape swimming in the brown shrimp crangon crangon

The Journal of experimental biology·1998

Optimizing oral anticoagulation management significantly reduces adverse events. Coordinated care models show lower rates of major hemorrhage and thrombotic events compared to routine medical care, improving patient outcomes.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Health Services Research

Background:

  • Oral anticoagulation therapy presents a high risk/benefit profile due to its narrow therapeutic index and patient-specific factors.
  • Anticoagulation management itself is increasingly recognized as a critical risk factor for adverse events.

Purpose of the Study:

  • To compare the efficacy and safety of two distinct oral anticoagulation management models: routine medical care and coordinated care.
  • To evaluate the impact of anticoagulation management strategies on adverse event rates and healthcare utilization.

Main Methods:

  • Literature review and synthesis of existing studies comparing routine medical care with coordinated care models for oral anticoagulation.
  • Analysis of reported rates of major hemorrhage and thrombotic events across different management strategies.

Related Experiment Videos

Main Results:

  • Coordinated care models demonstrate significantly lower rates of major hemorrhage (approximately 3.5%) compared to routine medical care (approximately 10%).
  • Thrombotic event rates are also substantially reduced under coordinated care (approximately 3.5%) versus routine care (approximately 12%).
  • Fewer adverse events in coordinated care lead to cost savings through reduced hospitalizations and emergency room visits.

Conclusions:

  • Coordinated anticoagulation management services are associated with improved patient safety and reduced adverse events.
  • There is a strong clinical and economic rationale for the development and promotion of structured anticoagulation management services to maximize the benefits of oral anticoagulation therapy.